Evidence map›Paper›PMID 29142303›Full record

ArticleScientific reports2017

FUS toxicity is rescued by the modulation of lncRNA hsrω expression in Drosophila melanogaster.

Luca Lo Piccolo, Salinee Jantrapirom, Yoshitaka Nagai, Masamitsu Yamaguchi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in immunology · 2022
    Article
  4. Article
  5. International journal of molecular sciences · 2021
    Article
  6. Amyotrophic Lateral Sclerosis Genes inInternational journal of molecular sciences · 2021
    Review
  7. Epigenetic Regulation of ALS and CMT: A Lesson fromInternational journal of molecular sciences · 2021
    Review
  8. Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.Advances in experimental medicine and biology · 2021
    Article
  9. The lncRNAJournal of cell science · 2019
    Article
  10. Insights into the Functions of LncRNAs inInternational journal of molecular sciences · 2019
    Review
  11. Over-expression of Hsp83 in grossly depletedJournal of biosciences · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Luca Lo PiccoloDepartment of Applied Biology, The Center for Advanced Insect Research, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan. lucalopiccolo@gmail.com.ORCID 0000-0003-0558-356X
Salinee JantrapiromDepartment of Applied Biology, The Center for Advanced Insect Research, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan.
Yoshitaka NagaiDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Masamitsu YamaguchiDepartment of Applied Biology, The Center for Advanced Insect Research, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan.
Kyoto Institute of Technology · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FUS is an aggregation-prone hnRNP involved in transcriptional and post-transcriptional regulation that aberrantly forms immunoreactive inclusion bodies in a range of neurological diseases classified as FUS-proteinopathies. Although FUS has been extensively examined, the underlying molecular mechanisms of these diseases have not yet been elucidated in detail. We previously reported that RNAi of the lncRNA hsrω altered the expression and sub-cellular localization of Drosophila FUS in the central nervous system of the fly. In order to obtain a clearer understanding of the role of hsrω in FUS toxicity, we herein drove the expression of human FUS in Drosophila eyes with and without a hsrω RNAi background. We found that hFUS was largely soluble and also able to form aggregates. As such, hFUS was toxic, inducing an aberrant eye morphology with the loss of pigmentation. The co-expression of hsrω double-stranded RNA reduced hFUS transcript levels and induced the formation of cytoplasmic non-toxic hFUS-LAMP1-insoluble inclusions. The combination of these events caused the titration of hFUS molar excess and a removal of hFUS aggregates to rescue toxicity. These results revealed the presence of a lncRNA-dependent pathway involved in the management of aggregation-prone hnRNPs, suggesting that properly formed FUS inclusions are not toxic to cells.

Indexed as

AnimalsAnimals, Genetically ModifiedCentral Nervous SystemDrosophila melanogasterEyeGene Expression RegulationHeterogeneous-Nuclear RibonucleoproteinsLysosomal-Associated Membrane Protein 1PigmentationProtein AggregatesRNA-Binding Protein FUSRNA, Double-StrandedRNA, Long NoncodingFUS protein, humanHeterogeneous-Nuclear RibonucleoproteinsLysosomal-Associated Membrane Protein 1Protein AggregatesRNA-Binding Protein FUSRNA, Double-StrandedRNA, Long Noncoding

Identifiers

PMID29142303
PMCPMC5688078
OpenAlexW2767404177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.